The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Flavonoid Apigenin Inhibits Lipopolysaccharide-Induced Inflammatory Response through Multiple Mechanisms in Macrophages
Open accessAbstract
BACKGROUND: Apigenin is a non-toxic natural flavonoid that is abundantly present in common fruits and vegetables. It has been reported that apigenin has various beneficial health effects such as anti-inflammation and chemoprevention. Multiple studies have shown that inflammation is an important risk factor for atherosclerosis, diabetes, sepsis, various liver diseases, and other metabolic diseases. Although it has been long realized that apigenin has anti-inflammatory activities, the underlying functional mechanisms are still not fully understood. METHODOLOGY AND PRINCIPAL FINDINGS: In the present study, we examined the effect of apigenin on LPS-induced inflammatory response and further elucidated the potential underlying mechanisms in human THP-1-induced macrophages and mouse J774A.1 macrophages. By using the PrimePCR array, we were able to identify the major target genes regulated by apigenin in LPS-mediated immune response. The results indicated that apigenin significantly inhibited LPS-induced production of pro-inflammatory cytokines, such as IL-6, IL-1β, and TNF-α through modulating multiple intracellular signaling pathways in macrophages. Apigenin inhibited LPS-induced IL-1β production by inhibiting caspase-1 activation through the disruption of the NLRP3 inflammasome assembly. Apigenin also prevented LPS-induced IL-6 and IL-1β production by reducing the mRNA stability via inhibiting ERK1/2 activation. In addition, apigenin significantly inhibited TNF-α and IL-1β-induced activation of NF-κB. CONCLUSION AND SIGNIFICANCE: Apigenin Inhibits LPS-induced Inflammatory Response through multiple mechanisms in macrophages. These results provided important scientific evidences for the potential application of apigenin as a therapeutic agent for inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“arteriosclerosis, sepsis, obesity, diabetes, various liver diseases, inflammatory bowel disease, autoimmune diseases, allergy and cancer [2,3].”
BackgroundSchroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Flavonoids: a review of probable mechanisms of action and potential applications
Nijveldt, R. J., van Nood, E., van Hoorn, D. E., Boelens, P. G., van Norren, K., & van Leeuwen, P. A. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.4.418 · Cited by 3,075
Natural products: A continuing source of novel drug leads
Cragg, G. M., & Newman, D. J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.008 · Cited by 2,906
Dinarello, C. A. (2000) · Chest · doi:10.1378/chest.118.2.503 · Cited by 2,045
Flavonoid intake and risk of chronic diseases
Knekt, P., Kumpulainen, J., Järvinen, R., Rissanen, H., Heliövaara, M., Reunanen, A., Hakulinen, T., & Aromaa, A. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.3.560 · Cited by 1,752
Impact of Natural Products on Developing New Anti-Cancer Agents
Cragg, G. M., Grothaus, P. G., & Newman, D. J. (2009) · Chemical Reviews · doi:10.1021/cr900019j · Cited by 1,302
Recognition of lipopolysaccharide pattern by TLR4 complexes
Park, B. S., & Lee, J.-O. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.97 · Cited by 1,234
Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease
García-Lafuente, A., Guillamón, E., Villares, A., Rostagno, M. A., & Martínez, J. A. (2009) · Inflammation Research · doi:10.1007/s00011-009-0037-3 · Cited by 1,024
Anti-inflammatory Plant Flavonoids and Cellular Action Mechanisms
Kim, H. P., Son, K. H., Chang, H. W., & Kang, S. S. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj04003x · Cited by 1,014
A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention
Chen, A. Y., & Chen, Y. C. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2012.11.139 · Cited by 994
Cytokines in acute and chronic inflammation
Wright, T. M. (1997) · Frontiers in Bioscience · doi:10.2741/a171 · Cited by 963
Flavonoids as anti-inflammatory agents
Serafini, M., Peluso, I., & Raguzzini, A. (2010) · Proceedings of the Nutrition Society · doi:10.1017/s002966511000162x · Cited by 820
Apigenin: A Promising Molecule for Cancer Prevention
Shukla, S., & Gupta, S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0089-7 · Cited by 820
Effects of Flavonoids and other Polyphenols on Inflammation
González, R., Ballester, I., López-Posadas, R., Suárez, M. D., Zarzuelo, A., Martínez-Augustin, O., & Medina, F. S. D. (2011) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390903584094 · Cited by 569
Flavonoids: A versatile source of anticancer drugs
Sharma, N., Dobhal, M., Joshi, Y., & Chahar, M. (2011) · Pharmacognosy Reviews · doi:10.4103/0973-7847.79093 · Cited by 551
Control of Macrophage Activation and Function by PPARs
Chawla, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.216523 · Cited by 531
Apigenin and cancer chemoprevention: Progress, potential and promise (Review)
Patel, D., Shukla, S., & Gupta, S. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.1.233 · Cited by 526
NLRP3 inflammasomes link inflammation and metabolic disease
De Nardo, D., & Latz, E. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.05.004 · Cited by 425
Weinstein, S. L., Sanghera, J. S., Lemke, K., DeFranco, A. L., & Pelech, S. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42133-3 · Cited by 396 · cited 3×
“In macrophages, LPS activates ERK1/2, p38 MAPK, and Jun N-terminal kinase (JNK) [38].”
InfluentialThe NLRP3 inflammasome in health and disease: the good, the bad and the ugly
Menu, P., & Vince, J. E. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04440.x · Cited by 389
Flavonoids and Cancer Prevention: A Review of the Evidence
Romagnolo, D. F., & Selmin, O. I. (2012) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2012.702534 · Cited by 354
Cho, S.-Y., Park, S.-J., Kwon, M.-J., Jeong, T.-S., Bok, S.-H., Choi, W.-Y., Jeong, W.-I., Ryu, S.-Y., Do, S.-H., Lee, C.-S., et al. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1021624520740 · Cited by 350
Nicholas, C., Batra, S., Vargo, M. A., Voss, O. H., Gavrilin, M. A., Wewers, M. D., Guttridge, D. C., Grotewold, E., & Doseff, A. I. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.7121 · Cited by 339
A natural history of botanical therapeutics
Schmidt, B., Ribnicky, D. M., Poulev, A., Logendra, S., Cefalu, W. T., & Raskin, I. (2008) · Metabolism · doi:10.1016/j.metabol.2008.03.001 · Cited by 309
Jang, C.-H., Choi, J.-H., Byun, M.-S., & Jue, D.-M. (2006) · Rheumatology · doi:10.1093/rheumatology/kei282 · Cited by 305
Novel Insights into the Pharmacology of Flavonoids
Romano, B., Pagano, E., Montanaro, V., Fortunato, A. L., Milic, N., & Borrelli, F. (2013) · Phytotherapy Research · doi:10.1002/ptr.5023 · Cited by 246
Targeting Inflammatory Pathways by Flavonoids for Prevention and Treatment of Cancer
Prasad, S., Phromnoi, K., Yadav, V., Chaturvedi, M., & Aggarwal, B. (2010) · Planta Medica · doi:10.1055/s-0030-1250111 · Cited by 229
The Caspase-1 Inflammasome: A Pilot of Innate Immune Responses
Yu, H. B., & Finlay, B. B. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.08.007 · Cited by 224
Nuclear factor-κB1: Regulation and function
Pereira, S. G., & Oakley, F. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.05.004 · Cited by 213
Lund, S., Christensen, K. V., Hedtjärn, M., Mortensen, A. L., Hagberg, H., Falsig, J., Hasseldam, H., Schrattenholz, A., Pörzgen, P., & Leist, M. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.07.007 · Cited by 212
Xie, C., Kang, J., Li, Z., Schauss, A. G., Badger, T. M., Nagarajan, S., Wu, T., & Wu, X. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.06.013 · Cited by 195
Yamamoto, M., Yaginuma, K., Tsutsui, H., Sagara, J., Guan, X., Seki, E., Yasuda, K., Yamamoto, M., Akira, S., Nakanishi, K., et al. (2004) · Genes to Cells · doi:10.1111/j.1365-2443.2004.00789.x · Cited by 183
Inhibition of LPS‐stimulated pathways in macrophages by the flavonoid luteolin
Xagorari, A., Roussos, C., & Papapetropoulos, A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704803 · Cited by 181
Weiss, U. (2008) · Nature · doi:10.1038/454427a · Cited by 169
Flavonoids and metabolic syndrome
Galleano, M., Calabró, V., Prince, P. D., Litterio, M. C., Piotrkowski, B., Prieto, M. A. V., Miatello, R. M., Oteiza, P. I., & Fraga, C. G. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06511.x · Cited by 167
Kowalski, J., Samojedny, A., Paul-Samojedny, M., Pietsz, G., & Wilczok, T. (2005) · PubMed · Cited by 157
The effects of dietary flavonoids on the regulation of redox inflammatory networks
Izzi, V., Masuelli, L., Tresoldi, I., Sacchetti, P., Modesti, A., Galvano, F., & Bei, R. (2012) · Frontiers in bioscience · doi:10.2741/4061 · Cited by 139
Tanaka, T., & Takahashi, R. (2013) · Nutrients · doi:10.3390/nu5062128 · Cited by 128
The application of Chinese medicine to novel drug discovery
Sucher, N. J. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.739602 · Cited by 106
Zhang, A., Sun, H. J., Qiu, S., & Wang, X. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/257909 · Cited by 93
Takano‐Ishikawa, Y., Goto, M., & Yamaki, K. (2005) · Phytomedicine · doi:10.1016/j.phymed.2005.01.016 · Cited by 91
Zha, W., Liang, G., Xiao, J., Studer, E. J., Hylemon, P. B., Pandak, W. M., Wang, G., Li, X., & Zhou, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009069 · Cited by 87
Self-citationFlavonoids in Cancer Prevention
Park, E., & Pezzuto, J. M. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012802650075 · Cited by 80
Li, R.-R., Pang, L., Du, Q., Shi, Y., Dai, W., & Kai-sheng, Y. (2010) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970903420566 · Cited by 79
Sharma, H., Kanwal, R., Bhaskaran, N., & Gupta, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091588 · Cited by 78
Zhou, H., Brimson, S. J., Gurley, E. C., Chen, L., Ding, H., Studer, E. J., Pandak, W. M., Hu, W., Zou, T., Wang, J., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.04.008 · Cited by 77
Self-citationDuarte, S., Arango, D., Parihar, A., Hamel, P. P., Yasmeen, R., & Doseff, A. I. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917664 · Cited by 77
Satoh, T. K., Kambe, N., & Matsue, H. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.169 · Cited by 75
Johnson, J. L., & de Mejı́a, E. G. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300307 · Cited by 75
Nurmi, K., Virkanen, J., Rajamäki, K., Niemi, K., Kovanen, P. T., & Eklund, K. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078537 · Cited by 68
Chen, L., Brimson, S., Wu, X., Sun, L., Zha, W., Liang, G., Wang, X., Gurley, E. C., Studer, E. J., Hylemon, P. B., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.022 · Cited by 68
Self-citationDesai, P. J., & Thurmond, R. L. (2011) · European Journal of Immunology · doi:10.1002/eji.201040932 · Cited by 62
Chen, R., Hollborn, M., Grosche, A., Reichenbach, A., Wiedemann, P., Bringmann, A., & Kohen, L. (2014) · PubMed Central · Cited by 61
Kim, A. R., Cho, J. Y., Zou, Y., Choi, J. S., & Chung, H. Y. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977796 · Cited by 59
Kim, S., & Joo, Y. (2011) · Chonnam Medical Journal · doi:10.4068/cmj.2011.47.2.104 · Cited by 55
Han, J.-M., Jin, Y.-Y., Kim, H. Y., Park, K. H., Lee, W. S., & Jeong, T. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1019 · Cited by 54
Citrus Flavonoids and the Prevention of Atherosclerosis
Mulvihill, E. E., & Huff, M. W. (2012) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x11202020084 · Cited by 48
Huang, T., Ojcius, D. M., Young, J. D., Wu, Y., Ko, Y., Wong, T.-Y., Wu, C.-Y., Lu, C., & Lai, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041383 · Cited by 42
Rambaldi, A., Bettoni, S., Rossi, V., Tini, M. L., Giudici, G., Rizzo, V., Bassan, R., Mantovani, A., Barbui, T., & Biondi, A. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb08273.x · Cited by 20
Cited by
Oxidative Stress and Inflammation: What Polyphenols Can Do for Us?
Hussain, T., Tan, B., Yin, Y., Blachier, F., Tossou, M. C. B., & Rahu, N. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7432797 · Cited by 2,082
Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects
Zhang, H., & Tsao, R. (2016) · Current Opinion in Food Science · doi:10.1016/j.cofs.2016.02.002 · Cited by 1,519
Antidiabetic Properties of Dietary Flavonoids: A Cellular Mechanism Review
Vinayagam, R., & Xu, B. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0057-7 · Cited by 597
Blevins, H. M., Xu, Y., Biby, S., & Zhang, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.879021 · Cited by 587
Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids
Kawser Hossain, M., Abdal Dayem, A., Han, J., Yin, Y., Kim, K., Kumar Saha, S., Yang, G.-M., Choi, H., & Cho, S.-G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040569 · Cited by 495
Metadata
- Authors
- Zhang, X., Wang, G., Gurley, E. C., & Zhou, H.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-09-05
- Volume
- 9
- Issue
- 9
- Pages
- e107072
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2033029602
- Cited by
- 257
- References
- 61
- FWCI
- 11.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.